麻豆传媒

Qualifications

Fellow of the Higher Education Academy (FHEA)

PhD Molecular Biology of Cancer, 麻豆传媒

BSc Biomedical Sciences, 麻豆传媒 (First class)

Roles & Responsibilities

COST Action CA17138 EUROGRAFT Management Committee

COST Action CA17138 EUROGRAFT Science Communication Manager

Board Member (Science Communication): UK Society for Extracellular Vesicles (UKEV)

EDI Committee: Translational and Clinical Research Institute, 麻豆传媒

Editorial Positions

Review Editor: Frontiers in Immunology, Alloimmunity and Transplantation.

Editorial Board: International Journal of Immunology.

Guest Associate Editor: Frontiers Research Topic - New biomarkers in haematological disease

Awards

Wellcome Trust Translational Partnership – Translational Explorer Training Programme.

COST Association Scholarship - Cross-Cutting Activity in Science Communication,

Pathological Society Meeting Bursary – ISEV Annual Meeting, Barcelona. May 2018.

NanoString - RNA:Protein Panel International competition awardee.

Affymetrix - Tumour Profiling International competition awardee.

British Council Researcher Links Scholarship

Life Technologies - Ion Torrent™ Transcriptome Profiling International competition awardee

NanoString - PanCancer Panel Cancer Pathways International competition awardee.

Wellcome Trust - Advanced Course on Next Generation Sequencing Training Scholarship

First Poster Prize, EuroSciCon Meeting – Biomarker Discovery: Driving Technologies.

麻豆传媒 Graduate School Award – organization of NE Postgraduate Conference.

Websites

Current Research

My research interests lie in the multi-disciplinary role of extracellular vesicles (EV) and their molecular cargo in disease pathology, as novel biomarkers for diagnosis and prognosis, and as potential therapeutic targets, particularly in relation to immune-mediated inflammatory diseases (IMID) and rare disease. I have a current focus on acute & chronic graft versus host disease (GvHD) as a model system, where I aim to:

     • Identify EV biomarkers of GvHD/IMID

     • Investigate the pathophysiological role of EVs in GvHD and immunotherapy

     • Investigate the action of MSC-EVs as a GvHD therapeutic

Extracellular Vesicles

Extracellular vesicles (EVs) have attracted excitement in the scientific community due to their novel role in intercellular communication. These cell-derived nanoparticles mediate local and systemic cellular communication by transferring their genetic and proteomic cargo to recipient cells, thus, reprogramming target cells and regulating normal physiological processes and pathological conditions. EVs are present in biofluids, where they deliver systemic communication, demonstrating enticing promise for ‘Liquid Biopsies’ in cancer, autoimmune and cardiovascular disease. EVs are released by immune cells and can act as antigen-presenting vesicles, stimulate antitumoral immune responses or induce tolerogenic effects to suppress inflammation. The role of EVs in the pathophysiology of immunological disorders is an exciting field for research, and these potent genetic information agents offer translatable and cross-disciplinary importance as potential therapeutic targets, informative biological agents, predictive biomarkers, & potential indicators of immunotherapeutic response. More information about EV research in the UK can be found by visiting the UK Society for Extracellular Vesicles: https://www.ukev.org.uk/

Active Projects

Mechanisms of action of ECP therapy for GvHD, focusing on the role of EV-derived microRNAs.

The aim of this project is to investigate the circulatory EV microRNA profiles post-HSCT in GvHD patients receiving ECP-therapy. As ECP is safe to administer with few significant adverse effects, it has the potential for earlier use in the post-HSCT treatment of GvHD. Thus, further understanding the molecular mechanisms of ECP action, including EV microRNAs, may justify more timely use in clinical practice, as well as identify biomarkers for using ECP as first line or pre-emptive GvHD therapy.

EV-derived microRNAs as biomarkers for GvHD onset, response to therapy and clinical outcome.

This project aims to assess circulatory microRNA expression profiles in patients with GvHD at sequential time points, in order to identify EV-microRNA signature biomarkers for prospective diagnosis, prognosis, and disease stratification to drive personalised medicine strategies.

Mechanism of action of EVs as a therapeutic for GvHD.

The aim of this project is to elucidate the therapeutic efficacy and mechanistic action of EVs in GvHD target organs. We are investigating the molecular mechanisms of action of NK-EVs and their active microRNA content in the context of GvHD. In collaboration with Prof. M. Inngjerdingen (Oslo University), will can use a validated GvHD rat model to perform digital spatial profiling of global immune response and T-cell activation in GvHD target tissues, in combination with full profiling of the EV molecular cargo, in response to EV therapy.

Current Collaborations

1. Acute exercise extracellular vesicle release and content (Dr S. Orange, 麻豆传媒).

2. Molecular profiling of autologous serum treatment for ocular GvHD (Dr. I. Bojanic, University Hospital Zagreb).

3. Germline genetic biomarkers of chronic GvHD (Prof. J. Partanen, Finnish Blood Transfusion Service).

4. MicroRNA profiling of gastric aGvHD (Prof. E. Holler, Regensburg University).

5. MicroRNA profiling of innate lymphoid cells in aGvHD (Prof. M. Inngjerdingen, Oslo University).

6. ECP in the treatment of chronic lung allograft dysfunction (Profs. A Fisher & A Gennery, 麻豆传媒).

7. Serum microRNA biomarkers for chronic GvHD (Prof. K Bogunia-Kubik, Warsaw University).

8. Osteoarthritis and rheumatoid arthritis EV microRNA profiling (Dr. A Pratt, 麻豆传媒).

9. The effect of osteoarthritis MSC-EV on chondrogenesis (Dr X. Wang, 麻豆传媒).

Active funding

1. Wellcome Trust Translational Partnership

    Funder: Wellcome Trust. PI: Dr R. Crossland

2. ECP in the treatment of Chronic Lung Allograft Dysfunction (E-CLAD UK)

    Funder: The Bubble Foundation. PI: Dr A. Gennery. COI: Dr R. Crossland

3. EV Molecular Profiles in relation to ECP Response in patients with cGvHD

    Funder: 麻豆传媒 Hospitals NHS Charity. PI: Prof. M. Collin. COI: Dr R. Crossland

4. Investigating EV Molecular Profiles in relation to ECP response in GvHD patients

    Funder: Mallinckrodt. PI: Dr R. Crossland. COI: Prof. M Collin.

5. Serum EV microRNA profiles in relation to molecular pathology and ECP response in GvHD

    Funder: The Pathological Society of Great Britain. PI: Dr R Crossland. COI: Prof. M Collin.

6. Engineering Exosomes as NanoVehicles for Cancer Therapy

    Funder: Research Council Norway. PI: Prof. Marit Inngjerdingen. COI: Dr R Crossland

Collaborative links with Industry

Wellcome Trust Translational Explorer Programme, in partnership with Alcyomics Ltd.

Memberships

The UK Society for Extracellular Vesicles (UKEV)

The International Society for Extracellular Vesicles (ISEV)

The Pathological Society of Great Britain

UK Photopheresis Society

PhD

Mr Steven Bolton (current)

Thesis: Extracorporeal Photopheresis in the treatment of Chronic Lung Allograft Dysfunction (E-CLAD)

Mrs Kimberly Schell (current)

Thesis: Extracellular Vesicle MicroRNA Profiles in relation to ECP-Response in Patients with GvHD

Mrs Kay Carruthers (current)

Thesis: Pancreatic islet cell isolation & characterisation for clinical use and identifying novel potency assays

Dr Sadaf Atarod (alumnus)

Dr Rihab Gam (alumnus)

MRes

Annual MRes students

BSc

Annual undergraduate students from BSc Biomedical Sciences

Other Teaching

COST Action 17138 chronic GvHD Short Term Scientific Mission Coordinator and Supervisor (Current)

Versus Arthritis Tissue Engineering Centre Training and Development Programme Coordinator (Previous)

• Articles

  • Al-Shaibani M, Wang X-N, Tulah A, Crossland RE, Dickinson AM, Lovat PE. . Journal of Wound Care 2024, 33, clxxxii-cxciii.
  • Scalzone A, Sanjurjo-Rodriguez C, Berlinguer-Palmini R, Dickinson AM, Jones E, Wang X-N, Crossland RE. . Bioengineering 2024, 11(4), 388.
  • Nihtila J, Salmenniemi U, Itala-Remes M, Crossland RE, Gallardo D, Bogunia-Kubik K, Lacina P, Bieniaszewska M, Giebel S, Hyvarinen K, Kekalainen E, Ritari J, Partanen J. . Human Immunology 2024, 85(3), 110791.
  • Rosenberger A, Crossland RE, Dressel R, Kube D, Wolff D, Wulf G, Bickeboller H, Dickinson A, Holler E. . Frontiers in Immunology 2024, 15, 1280876.
  • Newman AM, Zaka M, Zhou P, Blain AE, Erhorn A, Barnard A, Crossland RE, Wilkinson S, Enshaei A, De Zordi J, Harding F, Taj M, Wood KM, Televantou D, Turner SD, Burke GAA, Harrison CJ, Bomken S, Bacon CM, Rand V. . Leukemia 2022, 36(3), 781-789.
  • Crossland RE, Norden J, Ghimire S, Juric MK, Pearce KF, Lendrem C, Collin M, Mischak-Weissinger E, Holler E, Greinix HT, Dickinson AM. . Frontiers in Immunology 2021, 12, 639171.
  • Wielinska J, Crossland RE, Lacina P, Swierkot J, Bugaj B, Dickinson AM, Bogunia-Kubik K. . Disease Markers 2021, 2021, 2924935.
  • Sanjurjo-Rodriguez C, Crossland RE, Reis M, Pandit H, Wang X-N, Jones E. . Stem Cells International 2021, 2021, 7232773.
  • Atarod S, Norden J, Bibby LA, Janin A, Ratajczak P, Lendrem C, Pearce KF, Wang XN, O'Reilly S, Van Laar JM, Collin M, Dickinson AM, Crossland RE. . Frontiers in Immunology 2018, 9, 1485.
  • Ahmed FW, Bakhashab S, Bastaman IT, Crossland RE, Glanville M, Weaver JU. . International Journal of Molecular Sciences 2018, 19(10), 3242.
  • Crossland RE, Norden J, Juric MK, Pearce KF, Lendrem C, Bibby LA, Collin M, Greinix HT, Dickinson AM. . Frontiers in Immunology 2017, 8, 1446.
  • Noble RA, Bell N, Blair H, Sikka A, Thomas H, Phillips N, Nakjang S, Miwa S, Crossland R, Rand V, Televantou D, Long A, Keun HC, Bacon CM, Bomken S, Critchlow SE, Wedge SR. . Haematologica 2017, 102(7), 1247-1257.
  • Crossland RE, Norden J, Juric MK, Green K, Pearce KF, Lendrem C, Greinix HT, Dickinson AM. . Frontiers in Immunology 2017, 8, 308.
  • Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G. . Frontiers in Immunology 2017, 7, 660.
  • Jalapothu D, Boieri M, Crossland RE, Shah P, Butt IA, Norden J, Dressel R, Dickinson AM, Inngjerdingen M. . Frontiers in Immunology 2016, 7, 361.
  • Crossland RE, Norden J, Bibby LA, Davis J, Dickinson AM. . Journal of Immunological Methods 2016, 429, 39-49.
  • Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ. . Journal of Molecular Diagnostics 2015, 17(1), 19-30.
  • Mazumdar R, Evans P, Culpin R, Bailey J, Allsup D. . Leukemia Research 2013, 37(6), 614-618.
  • Culpin RE, Sieniawski M, Angus B, Menon GK, Proctor SJ, Milne P, McCabe K, Mainou-Fowler T. . Histopathology 2013, 63(6), 788-801.
  • Culpin RE, Sieniawski M, Proctor SJ, Menon G, Mainou-Fowler T. . Journal of Clinical Pathology 2013, 66(3), 249-252.
  • Culpin RE, Proctor SJ, Angus B, Crosier S, Anderson JJ, Mainou-Fowler T. . International Journal of Oncology 2010, 37(2), 367-376.
  • Anderson JJ, Fordham S, Overman L, Dignum H, Wood K, Proctor SJ, Crosier S, Angus B, Culpin RE, Mainou-Fowler T. . International Journal of Oncology 2009, 35(5), 961-971.
  • Culpin RE, Challen C, Wilkins B, Crosier S, Anderson JJ. . 2007.

• Book Chapter

  • Crossland RE, Macdonald J, Wang X-N. . In: Astatke M, ed. RNA Amplification and Analysis. New York: Springer US, 2024, pp.101-123.

• Conference Proceedings (inc. Abstracts)

  • Newman AM, Zaka M, Zhou P, Erhorn A, Barnard A, Crossland RE, Wilkinson S, Wood K, Televantou D, Harrison CJ, Bomken S, Bacon CM, Rand V. . In: 50th Congress of the International Society of Paediatric Oncology (SIOP). 2019, Kyoto, Japan: John Wiley & Sons, Inc.
  • Zaka M, Crossland RC, Barnard A, Erhorn A, Wilkinson S, Bomken S, Bacon CM, Rand V. . In: Sixth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma. 2018, Rotterdam, Netherlands: John Wiley and Sons Ltd.
  • Newman AM, Zaka M, Zhou P, Erhorn A, Crossland RE, Wilkinson S, Enshaei A, Taj M, Wood K, Televantou D, Turner SD, Burke A, Harrison CJ, Bomken S, Bacon CM, Rand V. . In: Sixth International Symposium on Childhood, Adolescent and Young Adult Non‐Hodgkin Lymphoma. 2018, Rotterdam, Netherlands: John Wiley and Sons Ltd.
  • Zhou P, Enshaei A, Newman AM, Chagaluka G, Lampert I, Van Noorden S, Erhorn A, Barnard A, Crossland RE, Wilkinson S, Nakang S, Moorman AV, Wood K, Televantou D, Carey P, Bomken S, Bacon CM, Bailey S, Molyneux E, Rand V. . In: 50th Congress of the International Society of Paediatric Oncology (SIOP). 2018, Kyoto, Japan: John Wiley and Sons Inc.
  • Zhou P, Enshaei A, Newman AM, Banda K, Chagaluka G, Lampert I, Van Noorden S, Erhorn A, Barnard A, Crossland RE, Wilkinson S, Nakjang S, Moorman AV, Wood K, Televantou D, Carey P, Bomken S, Bacon CM, Bailey S, Molyneux E, Rand V. . In: Sixth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma. 2018, Rotterdam, Netherlands: John Wiley & Sons Ltd.
  • Crossland RE, Norden J, Collin M, Dickinson A. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey: Nature Publishing Group.
  • Crossland RE, Norden J, Bibby L, Collin M, Dickinson A. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey: Nature Publishing Group.
  • Gam R, Norden J, Crossland R, Pearce K, Holler E, Dressel R, Dickinson A. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey.
  • Gam R, Norden J, Crossland R, Pearce K, Holler E, Dressel R, Dickinson AM, Framework CellEurope Project, Professor Anne Dickinson Univ Newc. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey: Nature Publishing Group.
  • Gam R, Norden J, Crossland R, Pearce K, Dickinson A. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey.
  • Gam R, Norden J, Crossland R, Pearce K, Dickinson AM, Univ 麻豆传媒 Upon Tyne. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey: Nature Publishing Group.
  • Zhou P, Crossland R, Erhorn A, Rand V. . In: Fifth International Symposium on Childhood Adolescent and Young Adult Non-Hodgkin Lymphoma. 2015, Varese, Italy: British Journal of Haematology.
  • Zhou PX, Crossland R, Erhorn A, Rand V. . In: Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma. 2015, Varese, Italy: Wiley.
  • Crossland RE, Green K, Bacon C, Rand V. . In: Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma. 2015, Varese, Italy: Wiley.
  • Atarod S, Pearce K, Norden J, Lendrem C, Crossland R, Wang X, Sviland L, Janin A, Collin M, Dickinson A. . In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT). 2015, Istanbul, Turkey.
  • Crossland RE, Norden J, Bibby L, Davis J, Dickinson AM. . In: 56th ASH Annual Meeting and Exposition. 2014, San Francisco, CA, USA: American Society of Hematology.
  • Crossland RE, Norden J, Collin M, Dickinson AM. . In: 56th ASH Annual Meeting and Exposition. 2014, San Francisco, CA, USA: American Society of Hematology.
  • Rand V, Johnstone S, Crossland RE, Wilkinson S, Hall AG. . In: 56th ASH Annual Meeting and Exposition. 2014, San Francisco, CA: American Society of Hematology.
  • Crossland RE, Mainou-Fowler T, Sieniawski M, Bacon C, Rand V. . In: 56th ASH Annual Meeting and Exposition. 2014, San Francisco, CA: American Society of Hematology.
  • Culpin R, Pearce K, Bailey J, Pointon J, Sunter N, Bailey J, Evans P, Allsup D, Allan J, Mainou-Fowler T. . In: International Journal of Molecular Medicine. 2011, Spandidos Publications.
  • Culpin R, Sieniawski M, Anderson J, Angus B, Proctor S, Menon G, McCabe K, Milne P, Crosier S, Mainou-Fowler T. . In: International Journal of Molecular Medicine. 2011, Spandidos Publications.
  • Culpin RE, Pearce K, Bailey JR, Sunter NJ, Pointon JC, Proctor SJ, Allsup DJ, Allan JM, Mainou-Fowler T. . In: Blood: 52nd Annual Meeting of the American Society of Hematology. 2010, Orlando, Florida, USA: American Society of Hematology.
  • Culpin RE, Pearce K, Bailey JR, Sunter NJ, Pointon JC, Proctor SJ, Allsup DJ, Allan JM, Fowler TM. . In: Blood: 52nd Annual Meeting of the American Society of Hematology (ASH). 2010, Orlando, Florida, USA: American Society of Hematology.
  • Culpin RE, Anderson JJ, Angus B, Proctor SJ, Crosier S, Mainou-Fowler T. . In: British Journal of Haematology: 50th Annual Scientific Meeting of the British Society for Haematology. 2010, Edinburgh, UK: Wiley-Blackwell Publishing Ltd.
  • Culpin RE, Anderson JJ, Angus B, Proctor SJ, Crosier S, Mainou-Fowler T. . In: EJC Supplements: 21st Meeting of the European Association for Cancer Research. 2010, Oslo, Norway: Pergamon.

• Reviews

  • Bojanic I, Worel N, Pacini CP, Stary G, Piekarska A, Flinn AM, Schell KJ, Gennery AR, Knobler R, Lacerda JF, Greinix HT, Pulanic D, Crossland RE. . Frontiers in Immunology 2023, 14, 1086006.
  • Gail LM, Schell KJ, Lacina P, Strobl J, Bolton SJ, Steinbakk Ulriksen E, Bogunia-Kubik K, Greinix H, Crossland RE, Inngjerdingen M, Stary G. . Frontiers in Immunology 2023, 14, 1199422.
  • Doglio M, Crossland RE, Alho AC, Penack O, Dickinson AM, Stary G, Lacerda JF, Eissner G, Inngjerdingen M. . Frontiers in Immunology 2022, 13, 1045168.
  • Partanen J, Hyvarinen K, Bickeboller H, Bogunia-Kubik K, Crossland RE, Ivanova M, Perutelli F, Dressel R. . Frontiers in Immunology 2020, 11, 575492.
  • Crossland RE, Perutelli F, Bogunia-Kubik K, Mooney N, Milutin Gasperov N, Pucic-Bakovic M, Greinix H, Weber D, Holler E, Pulanic D, Wolff D, Dickinson AM, Inngjerdingen M, Grce M. . Frontiers in Immunology 2020, 11, 602547.
  • Gam R, Shah P, Crossland RE, Norden J, Dickinson AM, Dressel R. . Frontiers in Immunology 2017, 8, 380.